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Background: Most scales that assess the presence and severity of psychotic symptoms often measure a broad
range of experiences and behaviours, something that restricts the detailed measurement of specific symptoms such
as delusions or hallucinations. The Psychotic Symptom Rating Scales (PSYRATS) is a clinical assessment tool that
focuses on the detailed measurement of these core symptoms. The goal of this study was to examine the
psychometric properties of the French version of the PSYRATS.
Methods: A sample of 103 outpatients suffering from schizophrenia or schizoaffective disorders and presenting
persistent psychotic symptoms over the previous three months was assessed using the PSYRATS. Seventy-five
sample participants were also assessed with the Positive And Negative Syndrome Scale (PANSS).
Results: ICCs were superior to .90 for all items of the PSYRATS. Factor analysis replicated the factorial structure of
the original version of the delusions scale. Similar to previous replications, the factor structure of the hallucinations
scale was partially replicated. Convergent validity indicated that some specific PSYRATS items do not correlate with
the PANSS delusions or hallucinations. The distress items of the PSYRATS are negatively correlated with the
grandiosity scale of the PANSS.
Conclusions: The results of this study are limited by the relatively small sample size as well as the selection of
participants with persistent symptoms. The French version of the PSYRATS partially replicates previously published
results. Differences in factor structure of the hallucinations scale might be explained by greater variability of its
elements. The future development of the scale should take into account the presence of grandiosity in order to
better capture details of the psychotic experience.
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Psychosis is a complex disorder that expresses itself in a
variety of different ways. The clinical assessment of the ex-
perience of psychosis is a challenge for health care profes-
sionals to communicate precisely amongst one another. It
is also difficult to accurately measure the efficacy of treat-
ments. Different scales have been developed to measure* Correspondence: j.favrod@ecolelasource.ch
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These tools, such as the Positive and Negative Syndrome
Scale (PANSS) [1], the Scale for the Assessment of Posi-
tive Symptoms (SAPS) [2] or the Brief Psychiatric Rating
Scale (BPRS) [3], measure a broad range of experiences
and behaviours, something which restricts the detailed
measurement of specific symptoms [4]. These scales have
few items dedicated to the measurement of delusions or
hallucinations, both of which are key symptoms of the
psychotic experience. These symptoms are summarized as
single broad scores without taking into account the multi-
dimensional features of the experience. The various
dimensions of the psychotic experience include the degreeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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about auditory hallucinations are held, the level of pre-
occupation it engenders, the degree of distress experi-
enced as well as the behavioural responses used to cope
with the experience [4]. These various dimensions may re-
spond differentially to pharmacological [5-7] and psycho-
logical treatments [8-10].
Although there is some inconsistency in the literature
about the chosen dimensions of delusions or hallucina-
tions, assessment tools limited to a single item for key
symptoms will miss large parts of the complex nature of
such symptoms.
Haddock et al. [11] developed the Psychotic Symptom
Rating Scales (PSYRATS) in order to improve the meas-
urement of various dimensions of psychotic symptoms.
The PSYRATS contains separate scales for auditory hal-
lucinations and delusions. The PSYRATS auditory hallu-
cination scale includes eleven items and the delusion
scale includes six, all rated from zero to four. The psy-
chometrics qualities of the PSYRATS indicate good in-
ternal consistency, sensitivity to changes, relationships
with other measures of symptoms, inter-rater and retest
reliability. The properties of the PSYRATS have been
studied with various populations: hospitalized patients
or day-treatment patients with first episode of schizo-
phrenia or related disorders [12], recently relapsed
patients with schizophrenia and schizoaffective disorders
[4], hospitalized patients [13] and a mixed population of
hospitalized patients and outpatients with schizophrenia
and schizoaffective disorders [11], and patients with
mental retardation [14]. The auditory hallucination scale
has also been validated in Spanish [15].
In the initial study, the factor analysis yielded three in-
dependent factors for the auditory hallucination scale:
emotional characteristics, physical characteristics and
cognitive interpretation [11]. Two factors were reported
in relation to the delusion scale, designated as emotional
characteristics and cognitive interpretation (Haddock
et al. 1999). The PSYRATS has been used as outcome
measures in a number of studies aimed at evaluating the
effectiveness of psychological interventions for psychosis
[16-19]. It has also been used to quantify the impact of
psychotic symptoms on the cognitive process [20,21].
However, the PSYRATS factor subscales have not been
consistently used. This may be due to the reported lack
of consistency in replications of the first factor solution
[4,11,13,12]. Whilst the PSYRATS scales provide a total
cumulative score for each symptom, the multidimen-
sional nature of the symptoms suggests that the total
score should not be presented alone. This has driven
some researchers to report their use of PSYRATS on the
basis of single items [22]. The use of single items has
also been recommended to assess specific changes dur-
ing therapy [4]. The aim of this study was to examinethe psychometric properties of the French version of the
PSYRATS in a sample of patients suffering from schizo-
phrenia spectrum disorders with persistent psychotic
symptoms. The two scales of the PSYRATS were evalu-
ated for inter-rater reliability and inter-relationships of
the items. In addition, construct and concurrent validity
were examined.
Methods
Recruitment and ethical approval
Participants were recruited from three studies on per-
sistent psychotic symptoms [9,23-25]. To be included in
the studies, participants had to meet the criteria for
ICD-10 schizophrenia or schizoaffective disorders. Other
inclusion criteria for these studies were the presence of
delusions or hallucinations greater than 2 on the PANSS
item P1 (delusion) or P3 (hallucination). Participants
needed to be experiencing these symptoms for the three
months prior to the study and with no change in anti-
psychotic medication during the two months before in-
clusion. Participants were recruited from among the
patients followed by the Rehabilitation unit of the
Community Psychiatry Service of the Department of
Psychiatry at the University Hospital of Lausanne and
from the Foundation HorizonSud in Marsens, both in
Switzerland. The Rehabilitation unit of the Community
Psychiatry Service is a comprehensive, recovery-oriented
outpatient program that provides a variety of services
organized around clinical case management.
HorizonSud is a foundation that provides a sheltered
workshop, transitional employment, and sheltered ac-
commodation in a range from nursing home accommo-
dation to independent apartments. The three studies
from which the sample was drawn received approval by
the ethics committee at the University of Lausanne and
all participants signed an informed consent form.
Participants
One hundred and three participants took part in the
study. Eligibility depended on the presence of persistent
delusions or auditory hallucinations during the previous
three months before consent was obtained. 41 (40%)
were female and 62 (60%) male. Diagnoses were
extracted from current clinical records and confirmed by
experienced clinicians; schizophrenia (90%) or schizoaf-
fective disorder (10%). The mean age was 36.9 years
(SD= 9.8). Both auditory hallucinations and delusions
were reported by 48 participants. Ninety-four partici-
pants reported having delusions, among them 46
reported delusions without auditory verbal hallucina-
tions. Fifty-five participants reported having auditory
verbal hallucinations, among them 9 without delusion.
Eighty-one participants have never been married, 10
were currently married, 2 separated and 10 divorced.
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were unemployed and 69 were working in sheltered
workshops. The others were working as volunteers,
housewives or students. All participants spoke French
fluently. Seventy-five participants were interviewed using
the items of the positive symptoms scale of the PANSS.
Instruments
Patients were assessed using the following instruments:
 Psychotic Symptom Rating Scales [11]. The
PSYRATS is a 17-item, five-point scale (0–4),
multidimensional measure of delusions and auditory
hallucinations. Symptoms from the previous week
were rated. Two scores were obtained: Auditory
Hallucinations Scale (11 items) and Delusions Scale
(6 items). The items for auditory hallucinations are:
frequency, duration, location, loudness, beliefs about
origin, negative content, intensity of negative
content, amount of distress, intensity of distress,
disruption of life and control. The items for
delusions are: amount of preoccupation, duration of
preoccupation, conviction, amount of distress,
intensity of distress and disruption of life. The
original English version of the PSYRATS was
independently translated by two mother tongue
French-speaking members of our workgroup and
compared until full agreement was found. The
translation was authorized by the main author of the
original version.
 Positive and Negative Syndrome Scale (PANSS)
[1,26,27]. The PANSS is a 30-item, seven point
(1–7) rating instrument used for the assessment of
phenomena associated with schizophrenia.
Symptoms from the previous two weeks were rated.
Seventy-five participants included in two studies
were assessed using the items of the positive
symptoms scale, and the anxiety (G2) and
depression (G6) items of the general
psychopathology scale.
For all patients, symptom rating assessments were per-
formed by clinicians trained to reliably administer these
measures. Regular random tests of inter-rater reliability
were conducted between the raters by independent rat-
ings of 2 raters for 15 assessments.
Statistical analysis
All analyses were conducted using IBM SPSS Statistics
version 20. The factor structure of the scales was
evaluated by principal component factor analysis with a
single varimax rotation with Kaiser Normalization.
Inter-rater reliability was assessed by intraclass correla-
tions (ICCs). Significance test results are quoted as two-tailed probabilities. Associations between PSYRATS and
PANSS items were examined using Spearman rank-
based correlations.
Results
The fifty-five participants with auditory hallucinations had
a mean score of 26.5 (SD=7.6; range= 8–38) on the audi-
tory hallucination scale. The 94 participants with delu-
sions had a mean score of 15.1 (SD= 3.6; range: 3–24)
on the delusions scale. High scores are indicative of more
severe symptoms.
Inter-rater reliability
Intraclass correlations for the positive symptom items of
the PANSS were good to excellent. ICC were: 0.87 for
delusion, 0.74 for conceptual disorganization, 0.95 for
hallucination, 0.82 for hyperactivity, 0.95 for grandiosity,
0.87 for suspiciousness/persecution and 0.73 for hostil-
ity. For the delusions scale of the PSYRATS, ICCs were
excellent, between 0.92 to 1.00. For the hallucinations
scale the ICCs were also excellent, between 0.90 to 1.00.
For both scales, the lowest ICC was obtained for the dis-
ruption to life item.
Inter-relationships items
For the delusions scale, four of the 15 correlations were
significant at the .01 level. Amount of preoccupation
was correlated with the duration of preoccupation (0.47)
and disruption to life (0.45); duration of preoccupation
with disruption to life (0.42); amount of distress with in-
tensity of distress (0.57). For the hallucinations scale,
fifteen of the 55 correlations were significant at the .01
level, as follows. Frequency correlated with intensity of
distress (0.40) and disruption to life (0.39); location with
origin of voice (0.45); loudness with disruption to life
(0.37); origin of voice with degree of negative con-
tent (0.54), intensity of distress (0.37) and controllability
(0.43); amount of negative content with degree of nega-
tive content (0.56), amount of distress (0.75), and inten-
sity of distress (0.49); degree of negative content with
amount of distress (0.67), intensity of distress (0.53), dis-
ruption to life (0.37) and controllability (0.33); amount
of distress with intensity of distress (0.77).
PSYRATS hallucination factor analysis
The factor structure of the auditory hallucinations was
explored using a principal component factor analysis
with a single varimax rotation. Only the participants
who reported auditory verbal hallucinations were
included in the factor analysis of the PSYRATS halluci-
nations scale items. A four-factor solution appears as an
optimal representation of the data structure (Kaiser cri-
terion). This solution explained 72% of the total vari-
ance. These four factors could be identified as: an
Table 2 PSYRATS Delusion scale factor analysis
1 2
Amount of preoccupation 0.76
Duration of preoccupation 0.74
Conviction 0.41
Amount of distress 0.74
Intensity of distress 0.73
Disruption to life 0.65
Eigenvalues 2.3 1.5
Cumulative percentage of variance 38.5 63.3
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interpretation factor (factor 2), a disruption factor (fac-
tor 3) and a physical characteristics factor (factor 4).
(See Table 1).
PSYRATS delusion factor analysis
Factor analysis of the delusion scale items using a princi-
pal components factor analysis with a single varimax ro-
tation identified two factors. Only those participants
who reported delusions were included in the factor ana-
lysis of the PSYRATS delusions scale items. A two factor
solution appears as an optimal representation of the data
structure (Kaiser criterion). This solution explained 63 %
of the total variance. The items tend to constitute a cog-
nitive interpretation factor (factor 1) and a distress factor
(factor 2). (See Table 2).
Convergent validity: relationships with other measures
of symptoms
Spearman rank correlations coefficients were calculated
between the PSYRATS auditory hallucinations and items
of the PANSS. The frequency of voice, origin of voice,
degree of negative content items and the total score of
the PSYRATS hallucinations scale were correlated at the
.01 level with the P3 hallucination item of the PANSS.
Duration, amount of distress, and intensity of distress
items were correlated at the .05 level with the P3 hallu-
cination item of the PANSS (see Table 3). The disruption
to life item of the PSYRATS hallucination scale was sig-
nificantly correlated with G6 depression (r = 0.35, 2-
tailed p = .03) and G2 anxiety (r = 0.50, 2-tailed p = .001)
items. The amount of preoccupation and the conviction
items and the total score of the PSYRATS delusions
scale were correlated at the .01 level with the P1 delu-
sion item of the PANSS. The duration of preoccupation
item of the PSYRATS delusions scale was correlated atTable 1 PSYRATS Hallucination scale factor analysis
1 2 3 4
Frequency 0.93
Duration 0.44
Location 0.78
Loudness 0.78
Origin of voice 0.81
Amount of negative content 0.86
Degree of negative content 0.76
Amount of distress 0.93
Intensity of distress 0.79
Disruption to life 0.72
Controllability 0.54
Eigenvalues 4.1 1.6 1.2 1.0
Cumulative percentage of variance 37.6 52.0 62.5 71.9the .05 level with the P1 delusion item of the PANSS.
The amounts of distress, intensity of distress and disrup-
tion to life items and the total score of the PSYRATS
delusions scale were also correlated with the G6 depres-
sion items of the PANSS (see Table 4). The G2 Anxiety
item of the PANSS was correlated with the disruption to
life item and the total score of the PSYRATS delusions
scale. The P5 grandiosity item of the PANSS was signifi-
cantly negatively correlated with the amount of distress
and intensity of distress items of the PSYRATS delusions
scale. The P6 suspiciousness/persecution item of the
PANSS was correlated with the amount of preoccupa-
tion, duration of preoccupation, disruption to life and
total score of the PSYRATS delusions scale.
Discussion
The current study presents the factor structure and the
relationship between items of the PSYRATS and items
of the PANSS with a population of French-speaking out-
patients having persistent psychotic symptoms. The par-
ticipants showed a total score close to that of recently
relapsed patients [4]. The factor structure of the delu-
sions scale of the PSYRATS is the same as in the originalTable 3 Correlations between items of the PSYRATS
hallucination scale and PANSS P3 Hallucination item
PANSS P3 Hallucination (N = 39)
Frequency 0.42**
Duration 0.33*
Location 0.07
Loudness 0.30
Origin of voice 0.46**
Amount of negative content 0.28
Degree of negative content 0.55**
Amount of distress 0.33*
Intensity of distress 0.34*
Disruption to life 0.26
Controllability 0.31
Total 0.58**
*2-tailed p < 0.05.
**2-tailed p < 0.01.
Table 4 Correlations between items of the PSYRATS delusion scale and PANSS items
PANSS P1
Delusion
PANSS G6
Depression
PANSS G2
Anxiety
PANSS P5
Grandiosity
PANSS P6 Suspiciousness/
persecution
(N= 72) (N = 72) (N= 72) (N = 72) (N= 72)
Amount of preoccupation 0.41** 0.08 0.11 0.16 0.40**
Duration of preoccupation 0.27* 0.13 0.30* 0.16 0.31*
Conviction 0.47** 0.02 0.15 0.19 0.15
Amount of distress 0.02 0.38** -0.05 -0.25* 0.17
Intensity of distress 0.13 0.43** 0.17 -0.24* 0.14
Disruption to life 0.14 0.31** 0.42** 0.07 0.35**
Total PSYRATS delusion 0.37** 0.45** 0.29* -0.03 0.43**
*2-tailed p < 0.05.
**2-tailed p < 0.01.
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episode psychosis study [12]. The factor structure of the
hallucinations scale shows a four- factor structure. Three
of them—emotional characteristics factor, cognitive in-
terpretation factor and physical characteristics factor—
appear as in previously published studies [4,11,13]. The
factor analysis for our study encountered the same diffi-
culties as previous studies did when replicating the fac-
torial structure of the original version of the
hallucinations scale. As in previously published studies,
an emotional factor appears clearly. [4,11-13]. The fre-
quency and duration items of auditory hallucination load
on a physical factor as in previous studies. The belief
about voice items load on a cognitive interpretation fac-
tor as in previous studies. Also, similar to previously
published studies, the location factor loads on a cogni-
tive factor [4,12,13]. The disruption to life item and the
loudness item load on a disruption factor as in the Steel
et al. study [4]. The controllability item load on a cogni-
tive factor close to the Drake et al. study [12]. As sug-
gested by Steel et al. [4], we probably lack a clear
understanding of the dimensions of hallucinatory experi-
ence. Moreover, the different evaluations of the PSY-
RATS have been carried out with dissimilar participant
populations with psychotic symptoms. The difficulty to
replicate the factor structure of the auditory hallucina-
tions scale of the PSYRATS with different populations
may be explained by a differential response between
hallucination and delusion to psychiatric treatment.
For example, Schneider et al. [7] have shown with
patients suffering from schizophrenia and auditory ver-
bal hallucinations that in the longitudinal course, a gen-
eral symptomatic decrease became apparent only for
auditory hallucinations but not for delusions. Loudness
of the voice and distress associated with auditory hallu-
cination decreased early compared to other aspects of
hallucination that took more time to fade. Chang et al.
[28] have described that cluster structure stabilizes
after 6 months of antipsychotic treatment, and the
changes in physical characteristics may not be the solesign of clinical improvement. The difficulty in replicat-
ing the factor structure may also be explained by the
heterogeneous nature and complex nature of auditory
hallucinations [29].
For the concurrent validity, the total score of the PSY-
RATS hallucinations significantly correlate with the P3
item (hallucination) of the PANSS. The total score of the
PSYRATS delusions significantly correlate with the P1
and P6 of the PANSS. Some individual items of the PSY-
RATS hallucinations or delusions scales do not respect-
ively correlate with the P3 Hallucination item and P1
Delusion item of the PANSS, suggesting that this last
item reflects selected aspects of psychotic symptomatol-
ogy as already demonstrated by Steel et al. [4] on a lar-
ger sample. In the current study, the P1 item of the
PANSS fails to assess the amount of distress and the in-
tensity of the distress associated with delusions. These
items are more related with the G6 depression item of
the PANSS. Inversely, the PSYRATS delusions scale does
not appear to take into account the elements associated
with delusions of grandiosity as measured with the P5
item of the PANSS. The amount of distress and inten-
sity of distress items are negatively associated with
grandiosity. A more detailed assessment of emotional
and behavioural reactions to grandiosity would be
worthwhile, in order to measure the effects of new psy-
chological interventions in this area. Grandiosity delu-
sions are associated with poor medication compliance
[30]. The same comment could apply to benevolent
voices and the auditory hallucination scale of the PSY-
RATS, which does not take into account the particular
emotional and behavioural reactions to that kind of
voice [31].
The present study does not replicate the Steel et al.
failure of the P3 item of the PANSS to assess the
negative content and distress associated with hallucina-
tions [4]. This might be explained by a population differ-
ence and the fact that our sample of participants with
hallucinations who were also assessed with the PANSS
was smaller.
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need refinement. The anchor point of the items have
varied between studies [4,11] and there is a difference in
precision of the description of the clinical observations
in comparison to the other items which are described
more precisely. In the present study, the lower inter-
rater ICCs were obtained for these two items. This may
lead to differences between the different factor analyses
published until yet.
A first limitation of the current study was the rela-
tively small sample of participants, something which
may have prevented the replication of previously pub-
lished results. The fact that participants were adminis-
tered a French version of the PANSS may also have
contributed to some of the unique findings of this study.
We selected participants with persistent psychotic symp-
toms, an often neglected population that is not easy to
reach. Beyond the specific interest for this subpopula-
tion, this was also a limitation of the study since results
may not be replicated in a normally distributed popula-
tion of persons suffering from schizophrenia. For the ex-
ternal validity, the smaller number of participants with
persistent hallucinations compared to participants with
persistent delusions might also have been a limitation of
the present study.
Conclusion
In conclusion, the French version of the PSYRATS par-
tially replicates previous evaluations of the scale in Eng-
lish or German. As in previous studies the factor
structure of the auditory hallucination scale appears less
stable. The longitudinal course of auditory hallucinations
need further research to better understand how the fac-
tor structure of the scale varies across time. The disrup-
tion to life items of both scales should be more detailed
to better tape the specific behavioural consequences of
psychotic symptoms. The future development of the
scale should take into account the emotional and behav-
ioural consequences of delusions associated with grandi-
osity and benevolent voices in order to capture better
important parts of the psychotic experience.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
JF, PF, SB, and CH contributed to the conception and design of the study. SR
and SB contributed to the acquisition of the data. JF, SR and FG contributed
to data analysis and interpretation of the data. JF and SR drafted the
manuscript. PF, SB, CH, SM and CB were involved in the critical revision of
the manuscript. All authors have given final approval of the version to be
published.
Acknowledgements
The study has been supported by a donation from Dr Alexander Engelhorn
and a grant from the Swiss National Science Fundation, grant number:
13DPD6-129784 Appendix: The French-version of the Psychotic Symptom
Rating Scales.Author details
1La Source, Health Campus of the University of Applied Sciences of Western
Switzerland, Lausanne, Switzerland. 2Department of Psychiatry, Community
Psychiatry Service, University Hospital Center of Lausanne, Lausanne,
Switzerland. 3Fondation HorizonSud, Marsens, Switzerland.
Received: 22 March 2012 Accepted: 25 September 2012
Published: 28 September 2012References
1. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale
(PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261–276.
2. Andreasen NC: The Scale for the Assessment of Positive Symptoms (SAPS).
Iowa City: The University of Iowa; 1984.
3. Overall JE: The Brief Psychiatric Ratin Scale (BPRS): recent developments
in ascertainment and scaling. Psychopharmacol Bull 1988, 24:97–99.
4. Steel C, Garety PA, Freeman D, Craig E, Kuipers E, Bebbington P, Fowler D,
Dunn G: The multidimensional measurement of the positive symptoms
of psychosis. Int J Methods Psychiatr Res 2007, 16(2):88–96.
5. Mizrahi R, Kiang M, Mamo DC, Arenovich T, Bagby RM, Zipursky RB, Kapur S:
The selective effect of antipsychotics on the different dimensions of the
experience of psychosis in schizophrenia spectrum disorders. Schizophr
Res 2006, 88(1–3):111–118.
6. Miller LJ: Qualitative changes in hallucinations. Am J Psychiatry 1996,
153(2):265–267.
7. Schneider SD, Jelinek L, Lincoln TM, Moritz S: What happened to the
voices? A fine-grained analysis of how hallucinations and delusions
change under psychiatric treatment. Psychiatry Res 2011, 188(1):13–17.
8. Moritz S, Jelinek L: Further evidence for the efficacy of association
splitting as a self-help technique for reducing obsessive thoughts.
Depress Anxiety 2011, 28(7):574–581.
9. Favrod J, Maire A, Bardy S, Pernier S, Bonsack C: Improving insight into
delusions: a pilot study of metacognitive training for patients with
schizophrenia. J Adv Nurs 2011, 67(2):401–407.
10. Khazaal Y, Favrod J, Azoulay S, Finot SC, Bernabotto M, Raffard S, Libbrecht
J, Dieben K, Levoyer D, Pomini V: "Michael's Game," a card game for the
treatment of psychotic symptoms. Patient Educ Couns 2011, 83(2):210–216.
11. Haddock G, McCarron J, Tarrier N, Faragher EB: Scales to measure
dimensions of hallucinations and delusions: the psychotic symptom
rating scales (PSYRATS). Psychol Med 1999, 29(4):879–889.
12. Drake R, Haddock G, Tarrier N, Bentall R, Lewis S: The Psychotic Symptom
Rating Scales (PSYRATS): Their usefulness and properties in first episode
psychosis. Schizophr Res 2007, 89(1–3):119–122.
13. Kronmuller KT, von Bock A, Grupe S, Buche L, Gentner NC, Ruckl S, Marx J,
Joest K, Kaiser S, Vedder H, et al: Psychometric evaluation of the Psychotic
Symptom Rating Scales. Compr Psychiatry 2011, 52(1):102–108.
14. Hatton C, Haddock G, Taylor JL, Coldwell J, Crossley R, Peckham N: The
reliability and validity of general psychotic rating scales with people
with mild and moderate intellectual disabilities: an empirical
investigation. J Intellect Disabil Res 2005, 49(Pt 7):490–500.
15. Gonzalez JC, Sanjuan J, Canete C, Echanove MJ, Leal C: Evaluation of
auditory hallucinations: the PSYRATS scale. Actas Esp Psiquiatr 2003,
31(1):10–17.
16. Durham RC, Guthrie M, Morton RV, Reid DA, Treliving LR, Fowler D,
Macdonald RR: Tayside-Fife clinical trial of cognitive-behavioural therapy
for medication-resistant psychotic symptoms. Results to 3-month
follow-up. Br J Psychiatry 2003, 182:303–311.
17. Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, Siddle R,
Drake R, Everitt J, Leadley K, et al: Randomised controlled trial of
cognitive-behavioural therapy in early schizophrenia: acute-phase
outcomes. Br J Psychiatry Suppl 2002, 43:s91–97.
18. Treatment of schizophrenia 1999: The expert consensus guideline series.
J Clin Psychiatry 1999, 60(Suppl 11):3–80.
19. Wykes T, Hayward P, Thomas N, Green N, Surguladze S, Fannon D, Landau
S: What are the effects of group cognitive behaviour therapy for
voices? A randomised control trial. Schizophr Res 2005, 77:201–210.
20. Fisher DJ, Grant B, Smith DM, Borracci G, Labelle A, Knott VJ: Effects of
auditory hallucinations on the mismatch negativity (MMN) in
schizophrenia as measured by a modified 'optimal' multi-feature
paradigm. Int J Psychophysiol 2011, 81(3):245–251.
Favrod et al. BMC Psychiatry 2012, 12:161 Page 7 of 7
http://www.biomedcentral.com/1471-244X/12/16121. Fisher DJ, Labelle A, Knott VJ: Alterations of mismatch negativity (MMN) in
schizophrenia patients with auditory hallucinations experiencing acute
exacerbation of illness. Schizophr Res 2012, 139(1–3):237–245.
22. Freeman D, Garety PA, Fowler D, Kuipers E, Bebbington PE, Dunn G: Why
do people with delusions fail to choose more realistic explanations for
their experiences? An empirical investigation. J Consult Clin Psychol
2004, 72(4):671–680.
23. Favrod J, Bardy Linder S, Pernier S, Mouron D, Schwyn C, Bonsack C, Pomini
V: Entraînement des habiletés métacognitives avec des personnes
atteintes de schizophrénie. In TCC et neurosciences. Edited by Cottraux J.
Issy-les-Moulineaux: Elsevier Masson SAS; 2009:103–114.
24. Favrod J, Ferrari P: Efficacy of metacognitive training to reduce delusions:
a randomized clinical trial. Research protocol. Swiss National Science
Fundation; 2009:25.
25. Schwyn C: Le monitoring de la source, vers une compréhension des
hallucinations auditives persistantes. Lausanne: Master thesis: Université
de Lausanne, Faculté des sciences sociales et politique, Institut de
psychologie; 2007:112.
26. Guelfi JD: The PANSS (Positive And Negative Symptom) Scale.
Encéphale 1997, 23(Spec No 2):35–38.
27. Lancon C, Auquier P, Llorca PM, Martinez JL, Bougerol T, Scotto JC:
Psychometric properties of PANSS (Positive and Negative
Syndrome Scale) in the French version in a sample of schizophrenic
patients. Encéphale 1997, 23(1):1–9.
28. Chang JS, Yi JS, Ahn YM, Kim JH, Kim YS: Stabilization of the internal
structure of persistent auditory verbal hallucinations in schizophrenia.
Aust N Z J Psychiatry 2009, 43(3):244–251.
29. Nayani TH, David AS: The auditory hallucination: a phenomenological
survey. Psychol Med 1996, 26(1):177–189.
30. Moritz S, Favrod J, Andreou C, Morrison AP, Bohn F, Veckenstedt R, Tonn P,
Karow A: Beyond the Usual Suspects: Positive Attitudes Towards Positive
Symptoms Is Associated With Medication Noncompliance in Psychosis.
Schizophr Bull 2012, doi:10.1093/schbul/sbs005.
31. Favrod J, Grasset F, Spreng S, Grossenbacher B, Hodé Y: Benevolent voices
are not so kind: the functional significance of auditory hallucinations.
Psychopathology 2004, 37(6):304–308.
doi:10.1186/1471-244X-12-161
Cite this article as: Favrod et al.: French version validation of the
psychotic symptom rating scales (PSYRATS) for outpatients with
persistent psychotic symptoms. BMC Psychiatry 2012 12:161.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
